Literature DB >> 21031584

Natural history of incidental World Health Organization grade II gliomas.

Johan Pallud1, Denys Fontaine, Hugues Duffau, Emmanuel Mandonnet, Nader Sanai, Luc Taillandier, Philippe Peruzzi, Rémy Guillevin, Luc Bauchet, Valérie Bernier, Marie-Hélène Baron, Jacques Guyotat, Laurent Capelle.   

Abstract

OBJECTIVE: Seizure is the presenting symptom in most of World Health Organization grade II gliomas (GIIGs). Rarely, a GIIG is discovered incidentally on imaging. Little is known about the natural course and prognosis of incidental GIIGs. The aim of the present study is to characterize their natural history and to investigate whether their clinical and radiological behaviors differ from those of symptomatic GIIGs.
METHODS: The clinical and radiological findings, treatments, and outcomes of 47 histologically-proven incidental GIIGs were compared with those of 1249 symptomatic GIIGs.
RESULTS: Incidental GIIGs differ significantly from symptomatic GIIGs: they have a female predominance (p = 0.05), smaller initial tumor volumes (p < 0.001), lower incidence of contrast enhancement (p = 0.009), and are more likely to undergo gross total surgical removal (p < 0.001). Proliferation rates were similar to that observed among symptomatic GIIGs. Younger age at the time of discovery, frontal lobes, and noneloquent brain regions were associated with incidental GIIGs, as compared to their symptomatic counterparts. When not treated, incidental GIIGs demonstrated radiological growth (median velocity of diametric expansion at 3.5 mm/year), and became symptomatic at a median interval of 48 months after radiological discovery. Overall, incidental discovery was associated with a significant survival benefit (p = 0.04).
INTERPRETATION: Incidental GIIGs are progressive tumors leading to clinical transformation toward symptomatic GIIGs. They may represent an earlier step in the natural history of a glioma than the symptomatic GIIGs.

Entities:  

Mesh:

Year:  2010        PMID: 21031584     DOI: 10.1002/ana.22106

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  35 in total

1.  Improving the time-machine: estimating date of birth of grade II gliomas.

Authors:  C Gerin; J Pallud; B Grammaticos; E Mandonnet; C Deroulers; P Varlet; L Capelle; L Taillandier; L Bauchet; H Duffau; M Badoual
Journal:  Cell Prolif       Date:  2011-12-14       Impact factor: 6.831

2.  Incidental finding of tumor while investigating subarachnoid hemorrhage: ethical considerations and practical strategies.

Authors:  Doniel Drazin; Kevin Spitler; Milos Cekic; Ashish Patel; George Hanna; Ali Shirzadi; Ray Chu
Journal:  Sci Eng Ethics       Date:  2012-10-13       Impact factor: 3.525

3.  Velocity of tumor spontaneous expansion predicts long-term outcomes for diffuse low-grade gliomas.

Authors:  Johan Pallud; Marie Blonski; Emmanuel Mandonnet; Etienne Audureau; Denys Fontaine; Nader Sanai; Luc Bauchet; Philippe Peruzzi; Marc Frénay; Philippe Colin; Rémy Guillevin; Valérie Bernier; Marie-Hélène Baron; Jacques Guyotat; Hugues Duffau; Luc Taillandier; Laurent Capelle
Journal:  Neuro Oncol       Date:  2013-02-07       Impact factor: 12.300

Review 4.  [Clinical magnetic resonance imaging : Frequent incidental cerebral findings].

Authors:  A Müller; P Ditter; S Weidauer; H-H Schild; E Hattingen
Journal:  Radiologe       Date:  2017-04       Impact factor: 0.635

Review 5.  Maximizing safe resection of low- and high-grade glioma.

Authors:  Shawn L Hervey-Jumper; Mitchel S Berger
Journal:  J Neurooncol       Date:  2016-05-12       Impact factor: 4.130

6.  Recent developments and future directions in adult lower-grade gliomas: Society for Neuro-Oncology (SNO) and European Association of Neuro-Oncology (EANO) consensus.

Authors:  David Schiff; Martin Van den Bent; Michael A Vogelbaum; Wolfgang Wick; C Ryan Miller; Martin Taphoorn; Whitney Pope; Paul D Brown; Michael Platten; Rakesh Jalali; Terri Armstrong; Patrick Y Wen
Journal:  Neuro Oncol       Date:  2019-07-11       Impact factor: 12.300

7.  Intra-rater variability in low-grade glioma segmentation.

Authors:  Hans Kristian Bø; Ole Solheim; Asgeir Store Jakola; Kjell-Arne Kvistad; Ingerid Reinertsen; Erik Magnus Berntsen
Journal:  J Neurooncol       Date:  2016-11-11       Impact factor: 4.130

Review 8.  Incidental diffuse low-grade gliomas: from early detection to preventive neuro-oncological surgery.

Authors:  Guilherme Lucas de Oliveira Lima; Marc Zanello; Emmanuel Mandonnet; Luc Taillandier; Johan Pallud; Hugues Duffau
Journal:  Neurosurg Rev       Date:  2015-11-27       Impact factor: 3.042

Review 9.  Awake surgery for hemispheric low-grade gliomas: oncological, functional and methodological differences between pediatric and adult populations.

Authors:  Gianluca Trevisi; Thomas Roujeau; Hugues Duffau
Journal:  Childs Nerv Syst       Date:  2016-09-20       Impact factor: 1.475

10.  A population-based study of low-grade gliomas and mutated isocitrate dehydrogenase 1 (IDH1).

Authors:  Rikke H Dahlrot; Bjarne W Kristensen; Jacob Hjelmborg; Jørn Herrstedt; Steinbjørn Hansen
Journal:  J Neurooncol       Date:  2013-07-02       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.